Quốc gia: Hoa Kỳ
Ngôn ngữ: Tiếng Anh
Nguồn: NLM (National Library of Medicine)
medroxyprogesterone acetate (UNII: C2QI4IOI2G) (medroxyprogesterone - UNII:HSU1C9YRES)
Cardinal Health
medroxyprogesterone acetate
medroxyprogesterone 10 mg
PRESCRIPTION DRUG
New Drug Application Authorized Generic
MEDROXYPROGESTERONE ACETATE- MEDROXYPROGESTERONE ACETATE TABLET CARDINAL HEALTH ---------- MEDROXYPROGESTERONE ACETATE TABLETS, USP DESCRIPTION Medroxyprogesterone acetate tablets contain medroxyprogesterone acetate, which is a derivative of progesterone. It is a white to off-white, odorless crystalline powder, stable in air, melting between 200 and 210°C. It is freely soluble in chloroform, soluble in acetone and in dioxane, sparingly soluble in alcohol and in methanol, slightly soluble in ether, and insoluble in water. The chemical name for medroxyprogesterone acetate is Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6- methyl-, (6α)-. The structural formula is: Each tablet for oral administration contains 2.5 mg, 5 mg or 10 mg of medroxyprogesterone acetate. Inactive ingredients: calcium stearate, corn starch, lactose, mineral oil, sorbic acid, sucrose, talc. The 2.5 mg tablet contains FD&C Yellow No. 6. CLINICAL PHARMACOLOGY Medroxyprogesterone acetate, administered orally or parenterally in the recommended doses to women with adequate endogenous estrogen, transforms proliferative into secretory endometrium. Androgenic and anabolic effects have been noted, but the drug is apparently devoid of significant estrogenic activity. While parenterally administered medroxyprogesterone acetate inhibits gonadotropin production, which in turn prevents follicular maturation and ovulation, available data indicate that this does not occur when the usually recommended oral dosage is given as single daily doses. PHARMACOKINETICS The pharmacokinetics of medroxyprogesterone acetate were determined in 20 postmenopausal women following a single-dose administration of eight medroxyprogesterone acetate tablets 2.5 mg or a single administration of two medroxyprogesterone acetate tablets 10 mg under fasting conditions. In another study, the steady-state pharmacokinetics of medroxyprogesterone acetate were determined under fasting conditions in 30 postmenopausal women following daily administration of one medroxyprogesterone acetate tablet Đọc toàn bộ tài liệu